NanoGroup S.A. (WSE:NNG)
Poland
· Delayed Price · Currency is PLN 2.720
-0.050 (-1.81%)
At close: Dec 5, 2025
NanoGroup Revenue
NanoGroup had revenue of -6.90K PLN in the twelve months ending September 30, 2025, down -441.75% year-over-year. In the year 2024, NanoGroup had annual revenue of 2.10K with 4.01% growth.
Revenue (ttm)
-6.90K
Revenue Growth
-441.75%
P/S Ratio
-12,679.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
87.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.10K | 81.00 | 4.01% |
| Dec 31, 2023 | 2.02K | -137.53K | -98.55% |
| Dec 31, 2022 | 139.55K | -352.94K | -71.66% |
| Dec 31, 2021 | 492.49K | -195.02K | -28.37% |
| Dec 31, 2020 | 687.51K | 169.78K | 32.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Oct 29, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |